What drives eyelid cancer in eastern morocco? a new study digs into the data
NCT ID NCT07723365
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study reviews the medical records of 20 people treated for eyelid carcinomas at a hospital in eastern Morocco. Researchers are examining patient characteristics, tumor types, and surgical approaches to better understand how these cancers present and are managed in this region.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What could go wrong
- This is a small, single-center retrospective review with only 20 patients, so findings may not apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Twenty patients were included in the study: 11 women (55%) and 9 men (45%). The mean age at diagnosis was 63.1 ± 22.3 years (range, 16-90 years). Regarding skin phototype, 5 patients (25%) had Fitzpatrick phototype II, 9 patients (45%) had phototype III, and 6 patients (30%) had phototype IV \[4\]. Most patients reported substantial lifetime sun exposure, often related to outdoor occupational activities such as farming or security work. Overall, chronic sun exposure was identified in 18 patients (90%).The remaining two patients (10%) had limited cumulative sun exposure due to their young age; however, they remained highly susceptible to UV radiation because of a history of xeroderma pigmentosum. Actinic keratosis was noted in one patient (5%), a history of eyelid trauma in one patient (5%), and chronic tobacco use in two patients (10%), both of whom were male. Xeroderma pigmentosum was present in two patients (10%). No history of arsenic exposure or prior radiotherapy was documented in
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * all patient with carcinoma Exclusion Criteria: * no exclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Basal cell carcinoma of eyelid are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oujda
Oujda, 60000, Morocco
More trials for these conditions
Other studies related to the condition(s) this trial covers.